Tilde Bio, Inc. is seeking a Masterβs-level Co-Op to join our Bioconjugation Chemistry team and help develop novel bioconjugation chemistries for site-selective protein modification.
You will design, synthesize, and evaluate new reactive handles and conjugation strategies, applying them to conjugate proteins with small molecules, linkers, payloads, and other functional moieties. This hands-on laboratory role offers real scientific ownership, collaborating with chemists, protein engineers, and
#J-18808-Ljbffr
MS Bioconjugation Chemistry Co-op β In-Office in Cambridge employer: Flagship Pioneering Co-Op Program
Quotient Therapeutics is an exceptional employer that fosters a collaborative and innovative work culture, ideal for those passionate about advancing drug development in a genetics-based biotech environment. Employees benefit from comprehensive growth opportunities, including professional development programmes and mentorship, while working in a dynamic setting that values creativity and strategic thinking. Located in a vibrant area, the company offers a unique chance to contribute to meaningful projects that have a real impact on patient outcomes.
Contact Details:
Flagship Pioneering Co-Op Program Recruitment Team